Effects of metalloprotease inhibitors on smooth muscle endothelindashconverting enzyme activity
- 31 January 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 49 (3) , 291-296
- https://doi.org/10.1016/0006-2952(94)00508-j
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Conversion of proendothelin-1 into endothelin-1 by aspartylproteasesInternational Journal of Peptide and Protein Research, 2009
- Intracellular Localization of Membrane-Bound Endothelin-Converting Enzyme from Rat LungJournal of Cardiovascular Pharmacology, 1993
- Physiology and pharmacology of endothelinsMedicinal Research Reviews, 1992
- Identification and Partial Purification of a Thiol Endothelin- Converting Enzyme from Porcine Aortic Endothelial CellsThe Journal of Biochemistry, 1992
- Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Conversion of big endothelin‐1 to endothelin‐1 by two types of metalloproteinases derived from porcine aortic endothelial cellsFEBS Letters, 1990
- Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymeBiochemical and Biophysical Research Communications, 1990
- Purification and characterization of putative endothelin converting enzyme in bovine adrenal medulla: Evidence for a cathepsin D-like enzymeBiochemical and Biophysical Research Communications, 1990
- Conversion of Big Endothelin-1 to 21-Residue Endothelin-1 Is Essential for Expression of Full Vasoconstrictor ActivityJournal of Cardiovascular Pharmacology, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988